Article ; Online: Gadolinium-based Contrast Agent Biodistribution and Speciation in Rats.
2023 Volume 309, Issue 1, Page(s) e230984
Abstract: Background Gadolinium retention has been observed in organs of patients with normal renal function; however, the biodistribution and speciation of residual gadolinium is not well understood. Purpose To compare the pharmacokinetics, distribution, and ... ...
Abstract | Background Gadolinium retention has been observed in organs of patients with normal renal function; however, the biodistribution and speciation of residual gadolinium is not well understood. Purpose To compare the pharmacokinetics, distribution, and speciation of four gadolinium-based contrast agents (GBCAs) in healthy rats using MRI, mass spectrometry, elemental imaging, and electron paramagnetic resonance (EPR) spectroscopy. Materials and Methods In this prospective animal study performed between November 2021 and September 2022, 32 rats received a dose of gadoterate, gadoteridol, gadobutrol, or gadobenate (2.0 mmol/kg) for 10 consecutive days. GBCA-naive rats were used as controls. Three-dimensional T1-weighted ultrashort echo time images and R2* maps of the kidneys were acquired at 3, 17, 34, and 52 days after injection. At 17 and 52 days after injection, gadolinium concentrations in 23 organ, tissue, and fluid specimens were measured with mass spectrometry; gadolinium distribution in the kidneys was evaluated using elemental imaging; and gadolinium speciation in the kidney cortex was assessed using EPR spectroscopy. Data were assessed with analysis of variance, Kruskal-Wallis test, analysis of response profiles, and Pearson correlation analysis. Results For all GBCAs, the kidney cortex exhibited higher gadolinium retention at 17 days after injection than all other specimens tested (mean range, 350-1720 nmol/g vs 0.40-401 nmol/g; |
---|---|
MeSH term(s) | Rats ; Humans ; Animals ; Contrast Media ; Gadolinium/pharmacokinetics ; Tissue Distribution ; Prospective Studies ; Brain ; Organometallic Compounds ; Gadolinium DTPA ; Magnetic Resonance Imaging/methods |
Chemical Substances | Contrast Media ; gadoteridol (0199MV609F) ; Gadolinium (AU0V1LM3JT) ; Organometallic Compounds ; Gadolinium DTPA (K2I13DR72L) |
Language | English |
Publishing date | 2023-11-20 |
Publishing country | United States |
Document type | Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't |
ZDB-ID | 80324-8 |
ISSN | 1527-1315 ; 0033-8419 |
ISSN (online) | 1527-1315 |
ISSN | 0033-8419 |
DOI | 10.1148/radiol.230984 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ue I Zs.106: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.